TrademarkOpen
Search / United States / 99218536

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

BFB

Allowed — statement of use stage
First Extension - Granted
Used for: Antibodies for medical purposes; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical…
Show more

Class 5: Antibodies for medical purposes; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of cancer, oncologic diseases and disorders, inflammation and immunity diseases and disorders, immunodeficiency diseases and disorders, genetic diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, kidney diseases and disorders, eye diseases and disorders, uveitis, glomerulosclerosis, glomerulonephritis, cardiovascu…
Class 42: Pharmaceutical research and development; Research and development services in the field of antibodies; Providing medical and scientific research information; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunology and inflammation diseases, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, uveitis, glomerulosclerosis, glomerulonephritis, and cardiovascular dise…

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 4 Jun 2025
    Application filed
    New Application Entered
  2. 24 Oct 2025
    Assigned to an examining attorney
    Assigned To Examiner
  3. 24 Oct 2025
    Approved for publication
    Approved For Pub - Principal Register
  4. 25 Nov 2025
    Published for opposition
    Published For Opposition
  5. 20 Jan 2026
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 21 Jul 2026
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
All 13 events
2026-07-21Sou Extension 1 Granted
2026-07-21Notice Of Approval Of Extension Request E-Mailed
2026-07-20Sou Teas Extension Received
2026-07-20Sou Extension 1 Filed
2026-01-20Noa Mailed - Sou Required From Applicant
2025-11-25Published For Opposition
2025-11-25Official Gazette Publication Confirmation E-Mailed
2025-11-19Notification Of Notice Of Publication E-Mailed
2025-10-24Assigned To Examiner
2025-10-24Approved For Pub - Principal Register
2025-10-10New Application Office Supplied Data Entered
2025-06-04New Application Entered
2025-06-04Application Filing Receipt Mailed

Goods & services by class

Class 5 Pharmaceuticals & supplements

Antibodies for medical purposes; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of cancer, oncologic diseases and disorders, inflammation and immunity diseases and disorders, immunodeficiency diseases and disorders, genetic diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, kidney diseases and disorders, eye diseases and disorders, uveitis, glomerulosclerosis, glomerulonephritis, cardiovascu…

Class 42 Technology & SaaS

Pharmaceutical research and development; Research and development services in the field of antibodies; Providing medical and scientific research information; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunology and inflammation diseases, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, uveitis, glomerulosclerosis, glomerulonephritis, and cardiovascular dise…

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 21 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.